4.5 Review

Redox Regulation of Mitochondrial ATP Synthase

Journal

TRENDS IN CARDIOVASCULAR MEDICINE
Volume 23, Issue 1, Pages 14-18

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2012.08.005

Keywords

-

Funding

  1. NHLBI NIH HHS [P01 HL081427, P50 HL084946, HHSN268201000032C, N01HV28180] Funding Source: Medline
  2. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081427, P50HL084946] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Reversible cysteine oxidative post-translational modifications (Ox-PTMs) represent an important mechanism to regulate protein structure and function. In mitochondria, redox reactions can modulate components of the electron transport chain (ETC), the F1F0-ATP synthase complex, and other matrix proteins/enzymes. Emerging evidence has linked Ox-FTMs to mitochondrial dysfunction and heart failure, highlighting some potential therapeutic avenues. Ox-PTMs can modify a variety of amino acid residues, including cysteine, and have the potential to modulate the function of a large number of proteins. Among this group, there is a selected subset of amino acid residues that can function as redox switches. These unique sites are proposed to monitor the cell's oxidative balance through their response to the various Ox-PTMs. In this review, the role of Ox-PTMs in the regulation of the F1F0-ATP synthase complex is discussed in the context of heart failure and its possible clinical treatment. (Trends Cardiovasc Med 23:14-18) (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available